<DOC>
	<DOCNO>NCT00041756</DOCNO>
	<brief_summary>Matrix metalloproteinases ( MMPs ) implicate cartilage degradation . PG-530742 inhibits MMPs , potentially limiting cartilage degradation disease progression . This study test efficacy safety PG-530742 treatment mild moderate knee osteoarthritis .</brief_summary>
	<brief_title>Efficacy Safety PG-530742 Treatment Mild Moderate Knee Osteoarthritis</brief_title>
	<detailed_description>Matrix metalloproteinases implicate cartilage degradation occur osteoarthritis . PG-530742 inhibits matrix metalloproteinases , thus potentially limiting cartilage degradation disease progression . This study test efficacy safety PG-530742 treatment mild moderate knee osteoarthritis .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>mild moderate knee osteoarthritis confirm radiographic technique . secondary knee osteoarthritis ; disease osteoarthritis could cause knee pain ; disease intervention ( surgery , intraarticular injection ) would impact knee pain mobility ; drug act potentially bone cartilage component knee joint .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Primary Disease : Knee Primary Osteoarthritis</keyword>
</DOC>